Maybe if we were faced with some severe and immediate threat to public health and the business were a manufacturer of essential medication, there might be some overriding public interest justification for adopting that sort of position in law, but I think it would need to be a crisis of that sort of level to justify such direct intervention. I don't think the situation we're talking about here is anywhere close to justifying it on similar grounds.
Nor do I see any obvious evidence that forcing the matter through regulatory action will motivate a shift to more desirable funding models for the affected businesses. First some good alternative models would have to be identified, and if we'd done that already, we probably wouldn't be having this conversation at all.
